Meta-analysis on resected pancreatic cancer: a comparison between adjuvant treatments and gemcitabine alone

BACKGROUND: Pancreatic cancer is a highly malignant tumor with a poor prognosis. Chemotherapy such as gemcitabine is still an important treatment. Gemcitabine (Gem) may prolong survival time and delay the development of recurrent disease after complete resection of pancreatic cancer. Currently, some...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Chen, Hua, He, Ruizhi, Shi, Xiuhui, Zhou, Min, Zhao, Chunle, Zhang, Hang, Qin, Renyi
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6199735/
https://ncbi.nlm.nih.gov/pubmed/30352573
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4948-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados